## TDG: TransDigm Group Incorporated - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -1.4% below STRENGTH zone (4.0-10.0%); PEG 3.18 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1291.60)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Transdigm group director Stein sells shares worth $23.8m**
- Source: Investing.com | 20251205T211524 | Somewhat-Bullish | Relevance: 100%
- Kevin M Stein, a director at TransDigm Group Inc (NYSE:TDG), sold 17,526 shares for approximately $23.8 million, while simultaneously acquiring the same number of shares through stock option exercise for $1.85 million. Following these transactions, Stein still holds 8,158 shares indirectly. The company recently reported strong Q4 fiscal year 2025 results, surpassing analyst expectations for EPS and revenue, leading to positive but mixed analyst sentiment with UBS raising its price target and Stifel lowering its own, both maintaining a Buy rating.

**2. Mirabella Financial Services LLP Invests $4.43 Million in Transdigm Group Incorporated $TDG**
- Source: MarketBeat | 20251205T130803 | Bullish | Relevance: 100%
- Mirabella Financial Services LLP has purchased a new stake of 2,916 shares, valued at approximately $4.43 million, in Transdigm Group Incorporated (NYSE:TDG) during the second quarter. This aerospace company recently exceeded earnings expectations with an EPS of $10.82 against a $10.33 consensus and reported revenues of $2.44 billion, an 11.5% year-over-year increase. Analysts currently rate TDG a "Moderate Buy" with a consensus price target of $1,576.29, despite recent insider share sales totaling over $54 million.

**3. TransDigm Group Inc. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251204T164300 | Bullish | Relevance: 100%
- Shares of TransDigm Group Inc. (TDG) rallied 1.70% to $1,360.10 on Thursday, outperforming competitors and ending a three-day losing streak. This occurred during a mixed trading session where the S&P 500 Index rose 0.11% and the Dow Jones Industrial Average fell 0.07%. The article highlights TDG's strong performance against broader market trends.

**4. Transdigm group director Stein sells shares worth $23.8m**
- Source: Investing.com | 20251205T221030 | Somewhat-Bullish | Relevance: 100%
- Kevin M Stein, a director at TransDigm Group INC (NYSE:TDG), sold 17,526 shares of common stock for approximately $23.8 million, while simultaneously exercising stock options to acquire the same number of shares for $1.85 million. Following these transactions, Stein indirectly holds 8,158 shares. The company recently reported strong Q4 2025 financial results, exceeding analyst expectations for EPS and revenue, leading to mixed but generally positive analyst sentiment.

**5. Transdigm group director Stein sells shares worth $23.8m**
- Source: Investing.com India | 20251205T214521 | Somewhat-Bullish | Relevance: 100%
- Kevin M Stein, a director at TransDigm Group INC, sold 17,526 shares totaling approximately $23.8 million, while simultaneously acquiring the same number of shares through stock option exercises. This transaction comes as TransDigm recently reported strong financial results for Q4 2025, beating analyst expectations for EPS and revenue. Analysts have issued mixed but generally positive sentiments, with UBS raising its price target and Stifel lowering its target while maintaining a Buy rating.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-14 | Morgan Stanley | $1660 | $1600 | +4% |
| 2025-11-14 | JP Morgan | $1435 | $1405 | +2% |
| 2025-11-13 | RBC Capital | $1400 | $1385 | +1% |
| 2025-11-13 | BMO Capital | $1500 | $1420 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-14 | Morgan Stanley | main | Overweight |
| 2025-11-14 | JP Morgan | main | Neutral |
| 2025-11-13 | RBC Capital | main | Sector Perform |
| 2025-11-13 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 22 ($2.49M) |
| Sells | 13 ($110.86M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+1.8%)
- Capital Internationa: 11.5% (+4.1%)
- Blackrock Inc.: 7.4% (-1.6%)
- Capital World Invest: 7.0% (-0.8%)
- JPMORGAN CHASE & CO: 4.5% (+26.5%)

### Key Risks

1. Heavy insider selling: $111M sold (13 transactions in 90 days).
2. Valuation risk: PEG 3.2x with declining EPS estimates leaves no margin for error.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 5 raises (avg +3%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.18 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROA 11%, margin 24%). Balance sheet: strong liquidity (3.2x). Insider selling cluster ($110.9M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $73.8B |
| Beta | 0.92 |
| 52W Range | $1183.60 - $1623.83 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.18 |
| Forward P/E | 29.5 |
| Current P/E | 35.1 |
| YoY Growth | 19.1% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 1.4% to -1.4% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.4pp (needs >4.0% for momentum thesis). Below SMA200 (0.97x), long-term trend not supportive. RSI neutral at 54. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.39% (CS: 42) | Neutral |
| RSI_14 | 54.4 | Neutral |
| MACD Histogram | 0.44 | Bullish |
| vs SMA20 | 1.009x | Above |
| vs SMA50 | 1.026x | Above |
| vs SMA200 | 0.973x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1346.86
- **Stop Loss:** $1291.60 (4.1% risk)
- **Target:** $1402.12 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 21
- **Position Value:** $28,284.06
- **Portfolio %:** 28.28%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-03 (Est: $8.00)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $10.05 | $10.82 | +7.6% |
| 2025Q2 | $9.90 | $9.60 | -3.0% |
| 2025Q1 | $8.95 | $9.11 | +1.8% |
| 2024Q4 | $7.74 | $7.83 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*